Holen Sie sich die Stockscreener-App
7.05
0.79%
0.05
Schlusskurs vom Vortag:
$7.00
Offen:
$7
24-Stunden-Volumen:
2.23M
Relative Volume:
0.32
Marktkapitalisierung:
$1.25B
Einnahmen:
$2.54B
Nettoeinkommen (Verlust:
$-207.36M
KGV:
-5.9244
EPS:
-1.19
Netto-Cashflow:
$151.25M
1W Leistung:
-0.91%
1M Leistung:
-5.93%
6M Leistung:
-15.51%
1J Leistung:
-25.89%
1-Tages-Spanne:
$6.96
$7.12
1-Wochen-Bereich:
$6.88
$7.15
52-Wochen-Spanne:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
155 E 44TH STREET, NEW YORK, NY
Vergleichen Sie TDOC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
7.055 | 1.24B | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
220.38 | 36.69B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
61.42 | 10.51B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.80 | 8.34B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
91.94 | 7.83B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
38.08 | 6.75B | 11.99B | 24.18M | 234.31M | 0.2956 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-07-25 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Is the Market Bullish or Bearish on Teladoc Health Inc? - Benzinga
HIMS Scales AI-Enabled Care as Platform Depth and Engagement Expand - The Globe and Mail
Japan's Telemedicine and AI-Driven Healthcare Adoption Propel - openPR.com
Why Teladoc Health Stock Jumped 15% This Morning - AOL.com
Chegg, Skillz, and Teladoc Shares Plummet, What You Need To Know - Yahoo Finance
(TDOC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Teladoc Health Buys Catapult Health In $65M Acquisition - MSN
Voya Investment Management LLC Sells 99,728,586 Shares of Teladoc Health, Inc. $TDOC - MarketBeat
Teladoc Health Held In-Line Rating in Late Ocotber as Evercore Reversed Price Target Back to $8 - MSN
Down 98% From Its All-Time High? Is It Finally Time to Buy This Former Market Darling? - Finviz
HIMS vs. TDOC: Which telehealth stock looks more compelling? - MSN
Can Teladoc Health Inc. (4LL) stock sustain margin levelsEarnings Per Share Trends & Affordable Trading Strategies - bollywoodhelpline.com
Teladoc Health (NYSE:TDOC) Stock Crosses Below 50-Day Moving AverageHere's Why - MarketBeat
Teladoc Health Inc. (TDOC): GenAI Advancements Amid Bank of America’s Price Target Adjustment - MSN
Will New Analyst Coverage Shape Teladoc’s Evolving Virtual Care Story for Investors (TDOC)? - Sahm
HIMS vs. TDOC: Which Telehealth Stock Looks More Compelling? - The Globe and Mail
Why Teladoc (TDOC) Stock Is Up Today - Finviz
Can Teladoc Health Inc. stock expand revenue streamsJuly 2025 Drop Watch & Technical Entry and Exit Alerts - DonanımHaber
Teladoc Health Stock Jumps on Barclays Coverage Initiation | Market AnalysisNews and Statistics - IndexBox
Barclays Initiates Coverage on Teladoc (TDOC) with Equal Weight at $8.50 - Finviz
Virtual Care Market to Reach US$ 72.73 Billion by 2033 at 13.2% - openPR.com
11 Best Healthcare AI Stocks to Buy Now - Insider Monkey
Earnings Beat: How geopolitical tensions affect Teladoc Health Inc. stockBond Market & Weekly Setup with High ROI Potential - moha.gov.vn
Will Teladoc Health Inc. stock return to pre crisis levelsTrade Entry Summary & Accurate Trade Setup Notifications - ulpravda.ru
Why Teladoc Health Inc. stock is favored by pension funds2025 Performance Recap & Expert Curated Trade Ideas - ulpravda.ru
Will Teladoc Health Inc. stock recover faster than market2025 Retail Activity & Low Risk High Win Rate Stock Picks - Улправда
Why Teladoc Health Inc. stock is popular among millennialsJuly 2025 Update & Capital Protection Trade Alerts - Улправда
Responsive Playbooks and the TDOC Inflection - news.stocktradersdaily.com
Teladoc Health, Inc. (NYSE:TDOC) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Online Doctor Consultation Market to Reach US$ 47.29 Billion - openPR.com
Teladoc Board Member J. Eric Evans to Retire - TipRanks
Teladoc Health Announces Board Retirement - TradingView — Track All Markets
Teladoc board member Evans to retire in 2026 - StreetInsider
Teladoc Health, Inc. Announces Retirement of J. Eric Evans as Director - marketscreener.com
Teladoc Health (TDOC): Revisiting Valuation After a Modest One-Month Share Price Rebound - Yahoo Finance
Teladoc Health, Inc.'s (NYSE:TDOC) Recent 4.7% Pullback Adds to One-year Year Losses, Institutional Owners May Take Drastic Measures - 富途牛牛
Forget Teladoc and buy this healthcare stock instead - MSN
Teladoc Health Earnings Notes - Trefis
TDOC (Teladoc Health) Days Inventory : 19.03 (As of Sep. 2025) - GuruFocus
Forget Teladoc and Buy This Healthcare Stock Instead - sharewise.com
Teladoc Health (NYSE:TDOC) CEO Charles Divita III Sells 17,138 Shares - MarketBeat
Teladoc Amends Incentive Plan to Increase Shares - TipRanks
Top Telemedicine Services for Hospitals: Leading Solutions Compared - MedCity News
Maple Rock Capital Partners Inc. Sells 659,062 Shares of Teladoc Health, Inc. $TDOC - MarketBeat
United States Telestroke Services Market to Reach USD 5.16 - openPR.com
Will Barclays’ Equal-Weight Initiation Reframe Teladoc’s (TDOC) Virtual Care Risk‑Reward Narrative? - Sahm
Teladoc Health CEO Charles Divita III Sells Shares to Cover Tax Obligations - TradingView — Track All Markets
Teladoc Health (NYSE: TDOC) CEO reports RSU vesting and tax-related sale - Stock Titan
CEO Divita III Files To Sell 17,138 Of Teladoc Health Inc [TDOC] - TradingView — Track All Markets
Hims & Hers Expands Its Technology-Driven Personalized Virtual Care - The Globe and Mail
Teladoc Health (NYSE:TDOC) Stock Rating Upgraded by Barclays - MarketBeat
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.59%
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):